AMFEX
Price
$18.58
Change
-$0.18 (-0.96%)
Updated
Jun 13 closing price
Net Assets
382.45M
VTSAX
Price
$142.91
Change
-$1.69 (-1.17%)
Updated
Jun 13 closing price
Net Assets
1.82T
Interact to see
Advertisement

AMFEX vs VTSAX

Header iconAMFEX vs VTSAX Comparison
Open Charts AMFEX vs VTSAXBanner chart's image
AAMA Equity
Price$18.58
Change-$0.18 (-0.96%)
VolumeN/A
Net Assets382.45M
Vanguard Total Stock Mkt Idx Adm
Price$142.91
Change-$1.69 (-1.17%)
VolumeN/A
Net Assets1.82T
AMFEX vs VTSAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
AMFEX vs. VTSAX commentary
Jun 15, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AMFEX is a Buy and VTSAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VTSAX has more cash in the bank: 1.82T vs. AMFEX (382M). VTSAX pays higher dividends than AMFEX: VTSAX (1.28) vs AMFEX (0.83). AMFEX was incepted earlier than VTSAX: AMFEX (8 years) vs VTSAX (25 years). AMFEX (1.17) is less costly to investors than VTSAX (0.04). AMFEX is a more actively managed with annual turnover of: 3.00 vs. VTSAX (2.00). VTSAX has a lower initial minimum investment than AMFEX: VTSAX (3000) vs AMFEX (10000). VTSAX annual gain was more profitable for investors over the last year : 10.07 vs. AMFEX (2.76). VTSAX return over 5 years is better than : 91.40 vs. AMFEX (61.52).
AMFEXVTSAXAMFEX / VTSAX
Total Expense Ratio1.170.042,925%
Annual Report Gross Expense Ratio1.170.042,925%
Fund Existence8 years25 years-
Gain YTD4.6881.365343%
Front LoadN/AN/A-
Min. Initial Investment100003000333%
Min. Initial Investment IRAN/AN/A-
Net Assets382M1.82T0%
Annual Yield % from dividends0.831.2865%
Returns for 1 year2.7610.0727%
Returns for 3 years30.5157.6153%
Returns for 5 years61.5291.4067%
Returns for 10 yearsN/A179.53-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
LMOPX34.12N/A
N/A
Patient Opportunity C
SESGX23.52N/A
N/A
Sit ESG Growth S
WPGSX10.29N/A
N/A
WPG Partners Select Small Cap Value Ins
OANBX36.54-0.34
-0.92%
Oakmark Equity and Income Institutional
FCUIX19.08-0.28
-1.45%
NYLI PineStone U.S. Equity Class I